WILLIAM PEACOCK to Diagnosis, Differential
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Diagnosis, Differential.
Connection Strength
0.368
-
Differentiation of cardiac and noncardiac dyspnea using bioelectrical impedance vector analysis (BIVA). J Card Fail. 2012 Mar; 18(3):226-32.
Score: 0.065
-
Emergency department perspectives on B-type natriuretic peptide utility. Congest Heart Fail. 2008 Jul-Aug; 14(4 Suppl 1):17-20.
Score: 0.051
-
Acoustic cardiography in the differential diagnosis of dyspnea. Congest Heart Fail. 2006 Jul-Aug; 12 Suppl 1:41-3.
Score: 0.044
-
Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ED-IMPACT trial. Acad Emerg Med. 2006 Apr; 13(4):365-71.
Score: 0.043
-
Retrospective review: the incidence of non-ST segment elevation MI in emergency department patients presenting with decompensated heart failure. Congest Heart Fail. 2003 Nov-Dec; 9(6):303-8.
Score: 0.037
-
Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis. Ann Intern Med. 2022 01; 175(1):101-113.
Score: 0.032
-
2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol. 2012 Jun 05; 59(23):2091-8.
Score: 0.017
-
Cardiac disease in the alcoholic patient. Emerg Med Clin North Am. 1990 Nov; 8(4):775-91.
Score: 0.015
-
Adjusting for clinical covariates improves the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnoea: a sub-study of HEARD-IT. Eur J Heart Fail. 2009 Nov; 11(11):1043-9.
Score: 0.014
-
State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008 Sep; 10(9):824-39.
Score: 0.013
-
Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications. Congest Heart Fail. 2008 Jul-Aug; 14(4 Suppl 1):25-9.
Score: 0.013
-
Up-and-coming markers: myeloperoxidase, a novel biomarker test for heart failure and acute coronary syndrome application? Congest Heart Fail. 2008 Jul-Aug; 14(4 Suppl 1):46-8.
Score: 0.013
-
Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes. Am J Cardiol. 2000 Feb 15; 85(4):421-6.
Score: 0.007
-
Clinical decision rules discriminate between fractures and nonfractures in acute isolated knee trauma. Ann Emerg Med. 1995 Oct; 26(4):429-33.
Score: 0.005